Skip to main content

Table 1 Immunohistochemical scores for KLK1, KLK6, KLK7, KLK8, KLK9 and KLK10 in astrocytoma patients

From: Prognostic significance of multiple kallikreins in high-grade astrocytoma

 

Intensity ± SD

Percent ± SD

IR ± SD

 

III

IV

P a

III

IV

P a

III

IV

P a

KLK1

1.7 ± 0.4

2.2 ± 0.4

0.0063**

3.7 ± 0.4

3.3 ± 0.7

0.096

5.4 ± 1.8

7.3 ± 2.4

0.031*

KLK6

1.5 ± 0.7

2.6 ± 0.4

0.0003***

2.0 ± 0.6

3.0 ± 0.7

0.0005***

2.4 ± 1.5

7.7 ± 2.4

<0.0001***

KLK7

2.0 ± 0.1

2.3 ± 0.4

0.0042**

3.9 ± 0.2

3.7 ± 0.4

0.057

5.9 ± 1.1

8.2 ± 2.1

0.003**

KLK8

1.1 ± 0.2

1.5 ± 0.5

0.0099**

3.8 ± 0.5

3.0 ± 0.8

0.0038**

3.0 ± 0.7

4.3 ± 1.6

0.022*

KLK9

1.4 ± 0.6

2.4 ± 0.5

0.0003***

3.4 ± 0.7

3.6 ± 0.5

0.42

4.6 ± 1.8

9.0 ± 1.9

0.0001***

KLK10

1.0 ± 0.0

1.4 ± 0.4

0.0012**

2.5 ± 1.2

3.0 ± 0.7

0.36

2.4 ± 1.4

3.9 ± 1.5

0.011*

  1. Mean and standard deviation of KLK1, KLK6, KLK7, KLK8, KLK9 and KLK10 staining intensity, percent tumor core stained and immunoreactivity score across 60 grade IV astrocytoma specimens
  2. *P < 0.05, **P < 0.01 and ***P < 0.001
  3. aKruskal-Wallis test
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us